Altamira Therapeutics Ltd - Warrants (29/03/2028) Net Tangible Assets

As of the most recent data (December 2024), CYTOW shows a net tangible assets of $6.6M. That compares with $6.5M in the prior-year period — up 1.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTOW's net tangible assets is now $6.6M (was $6.5M) — a 1.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Altamira Therapeutics Ltd - Warrants (29/03/2028) is outperforming or lagging.

Tracking CYTOW's net tangible assets over time shows whether Altamira Therapeutics Ltd - Warrants (29/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $6.6M That compares with $6.5M in the prior-year period — up 1.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Altamira Therapeutics Ltd - Warrants (29/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $6.6M) with ownership activity and broader fundamentals.

Altamira Therapeutics Ltd - Warrants (29/03/2028)'s net tangible assets is $6.6M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.